Founders Financial Securities’s Virtus Biotech ETF BBP Stock Holding History
Bought
Maintained
Sold
Other funds holding BBP
Founders Financial Securities's BBP Position: Q3 2026 in Review
Founders Financial Securities sold out of Virtus Biotech ETF (BBP) in Q3 2026, closing a stake of 2,247 shares — an estimated $216K sold.
Founders Financial Securities first reported a position in BBP in Q2 2026 and held it in 1 quarter. The position peaked at $216K in Q2 2026. 33 funds tracked by Wall St. Rank hold BBP as of Q3 2026.
- Founders Financial Securities reported no remaining Virtus Biotech ETF position as of Q3 2026 after selling out during the quarter.
- Founders Financial Securities sold 2,247 Virtus Biotech ETF shares in Q3 2026, an estimated $216K.
- Founders Financial Securities first reported a position in Virtus Biotech ETF in Q2 2026 and held it in 1 quarter.
- Founders Financial Securities's Virtus Biotech ETF position peaked at $216K in Q2 2026.
- 33 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2026.
Based on Founders Financial Securities's 13F filing for Q3 2026, filed 28 Oct 2026.